LYLLANA
These highlights do not include all the information needed to use LYLLANA safely and effectively. See full prescribing information for LYLLANA. LYLLANA (estradiol transdermal system) Initial U.S. Approval: 1975
09c472c6-a38a-4a3d-b048-6fefd52e2ad3
HUMAN PRESCRIPTION DRUG LABEL
Apr 20, 2022
Amneal Pharmaceuticals LLC
DUNS: 123797875
Products 5
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Estradiol
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (5)
Estradiol
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (5)
Estradiol
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (5)
Estradiol
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (5)
Estradiol
Product Details
FDA regulatory identification and product classification information